| Allan Rongguo Li, MD | |
|
Linden Blvd And Brookdale Plaza, Brooklyn, NY 11212 | |
| (718) 240-5321 | |
| (718) 240-5424 |
| Full Name | Allan Rongguo Li |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 42 Years |
| Location | Linden Blvd And Brookdale Plaza, Brooklyn, New York |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417097387 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZB0001X | Pathology - Blood Banking & Transfusion Medicine | 242402 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jamaica Hospital Medical Center | Jamaica, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jamaica Hospital | 2264324334 | 205 |
| Gastroenterology And Liver Disease Pc | 7113162439 | 2 |
News Archive
Previous studies have also linked hypertension to severe coronavirus disease (COVID-19). Now, a new study by researchers at the University of East Anglia's Norwich Medical School has found that the risk of severe COVID-19 and death was reduced for patients with high blood pressure who were taking Angiotensin-Converting Enzyme inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB).
The Wall Street Journal: "Republicans are looking beyond Sunday's expected vote on the Democrats' health-care overhaul to focus on strategies for striking back should it pass, ranging from challenges to the measure by individual states to a national repeal campaign. ... GOP leaders hope at a minimum that they can energize conservative activists and turn the electorate against the Democrats in the crucial period after the law's enactment, when both parties would be fighting to define it in the public's mind before the November elections."
A new health economic analysis, published today online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor, dabigatran etexilate, is cost-effective compared to current treatment options, particularly in "real-world" clinical practice.
Politico: Some state insurance commissioners are not happy with a proposal that would give the federal government the authority to centralize premium rate reviews of health insurance.
› Verified 7 days ago
| Entity Name | Flushing Hospital & Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548217763 PECOS PAC ID: 2668367483 Enrollment ID: O20040219000415 |
News Archive
Previous studies have also linked hypertension to severe coronavirus disease (COVID-19). Now, a new study by researchers at the University of East Anglia's Norwich Medical School has found that the risk of severe COVID-19 and death was reduced for patients with high blood pressure who were taking Angiotensin-Converting Enzyme inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB).
The Wall Street Journal: "Republicans are looking beyond Sunday's expected vote on the Democrats' health-care overhaul to focus on strategies for striking back should it pass, ranging from challenges to the measure by individual states to a national repeal campaign. ... GOP leaders hope at a minimum that they can energize conservative activists and turn the electorate against the Democrats in the crucial period after the law's enactment, when both parties would be fighting to define it in the public's mind before the November elections."
A new health economic analysis, published today online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor, dabigatran etexilate, is cost-effective compared to current treatment options, particularly in "real-world" clinical practice.
Politico: Some state insurance commissioners are not happy with a proposal that would give the federal government the authority to centralize premium rate reviews of health insurance.
› Verified 7 days ago
| Entity Name | Jamaica Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477505220 PECOS PAC ID: 2264324334 Enrollment ID: O20040427001519 |
News Archive
Previous studies have also linked hypertension to severe coronavirus disease (COVID-19). Now, a new study by researchers at the University of East Anglia's Norwich Medical School has found that the risk of severe COVID-19 and death was reduced for patients with high blood pressure who were taking Angiotensin-Converting Enzyme inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB).
The Wall Street Journal: "Republicans are looking beyond Sunday's expected vote on the Democrats' health-care overhaul to focus on strategies for striking back should it pass, ranging from challenges to the measure by individual states to a national repeal campaign. ... GOP leaders hope at a minimum that they can energize conservative activists and turn the electorate against the Democrats in the crucial period after the law's enactment, when both parties would be fighting to define it in the public's mind before the November elections."
A new health economic analysis, published today online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor, dabigatran etexilate, is cost-effective compared to current treatment options, particularly in "real-world" clinical practice.
Politico: Some state insurance commissioners are not happy with a proposal that would give the federal government the authority to centralize premium rate reviews of health insurance.
› Verified 7 days ago
| Entity Name | Vijaypal Arya Physician Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780660449 PECOS PAC ID: 3173561214 Enrollment ID: O20050420000356 |
News Archive
Previous studies have also linked hypertension to severe coronavirus disease (COVID-19). Now, a new study by researchers at the University of East Anglia's Norwich Medical School has found that the risk of severe COVID-19 and death was reduced for patients with high blood pressure who were taking Angiotensin-Converting Enzyme inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB).
The Wall Street Journal: "Republicans are looking beyond Sunday's expected vote on the Democrats' health-care overhaul to focus on strategies for striking back should it pass, ranging from challenges to the measure by individual states to a national repeal campaign. ... GOP leaders hope at a minimum that they can energize conservative activists and turn the electorate against the Democrats in the crucial period after the law's enactment, when both parties would be fighting to define it in the public's mind before the November elections."
A new health economic analysis, published today online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor, dabigatran etexilate, is cost-effective compared to current treatment options, particularly in "real-world" clinical practice.
Politico: Some state insurance commissioners are not happy with a proposal that would give the federal government the authority to centralize premium rate reviews of health insurance.
› Verified 7 days ago
| Entity Name | Chinatown Gastroenterology, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881888634 PECOS PAC ID: 1759392459 Enrollment ID: O20090317000079 |
News Archive
Previous studies have also linked hypertension to severe coronavirus disease (COVID-19). Now, a new study by researchers at the University of East Anglia's Norwich Medical School has found that the risk of severe COVID-19 and death was reduced for patients with high blood pressure who were taking Angiotensin-Converting Enzyme inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB).
The Wall Street Journal: "Republicans are looking beyond Sunday's expected vote on the Democrats' health-care overhaul to focus on strategies for striking back should it pass, ranging from challenges to the measure by individual states to a national repeal campaign. ... GOP leaders hope at a minimum that they can energize conservative activists and turn the electorate against the Democrats in the crucial period after the law's enactment, when both parties would be fighting to define it in the public's mind before the November elections."
A new health economic analysis, published today online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor, dabigatran etexilate, is cost-effective compared to current treatment options, particularly in "real-world" clinical practice.
Politico: Some state insurance commissioners are not happy with a proposal that would give the federal government the authority to centralize premium rate reviews of health insurance.
› Verified 7 days ago
| Entity Name | Anthony Foong Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467758300 PECOS PAC ID: 9032395744 Enrollment ID: O20110513000449 |
News Archive
Previous studies have also linked hypertension to severe coronavirus disease (COVID-19). Now, a new study by researchers at the University of East Anglia's Norwich Medical School has found that the risk of severe COVID-19 and death was reduced for patients with high blood pressure who were taking Angiotensin-Converting Enzyme inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB).
The Wall Street Journal: "Republicans are looking beyond Sunday's expected vote on the Democrats' health-care overhaul to focus on strategies for striking back should it pass, ranging from challenges to the measure by individual states to a national repeal campaign. ... GOP leaders hope at a minimum that they can energize conservative activists and turn the electorate against the Democrats in the crucial period after the law's enactment, when both parties would be fighting to define it in the public's mind before the November elections."
A new health economic analysis, published today online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor, dabigatran etexilate, is cost-effective compared to current treatment options, particularly in "real-world" clinical practice.
Politico: Some state insurance commissioners are not happy with a proposal that would give the federal government the authority to centralize premium rate reviews of health insurance.
› Verified 7 days ago
| Entity Name | Gastroenterology & Liver Disease Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891034500 PECOS PAC ID: 7113162439 Enrollment ID: O20130314000250 |
News Archive
Previous studies have also linked hypertension to severe coronavirus disease (COVID-19). Now, a new study by researchers at the University of East Anglia's Norwich Medical School has found that the risk of severe COVID-19 and death was reduced for patients with high blood pressure who were taking Angiotensin-Converting Enzyme inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB).
The Wall Street Journal: "Republicans are looking beyond Sunday's expected vote on the Democrats' health-care overhaul to focus on strategies for striking back should it pass, ranging from challenges to the measure by individual states to a national repeal campaign. ... GOP leaders hope at a minimum that they can energize conservative activists and turn the electorate against the Democrats in the crucial period after the law's enactment, when both parties would be fighting to define it in the public's mind before the November elections."
A new health economic analysis, published today online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor, dabigatran etexilate, is cost-effective compared to current treatment options, particularly in "real-world" clinical practice.
Politico: Some state insurance commissioners are not happy with a proposal that would give the federal government the authority to centralize premium rate reviews of health insurance.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Allan Rongguo Li, MD 1900 Hempstead Turnpike, Suite 500, East Meadow, NY 11554 Ph: (516) 542-1090 | Allan Rongguo Li, MD Linden Blvd And Brookdale Plaza, Brooklyn, NY 11212 Ph: (718) 240-5321 |
News Archive
Previous studies have also linked hypertension to severe coronavirus disease (COVID-19). Now, a new study by researchers at the University of East Anglia's Norwich Medical School has found that the risk of severe COVID-19 and death was reduced for patients with high blood pressure who were taking Angiotensin-Converting Enzyme inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB).
The Wall Street Journal: "Republicans are looking beyond Sunday's expected vote on the Democrats' health-care overhaul to focus on strategies for striking back should it pass, ranging from challenges to the measure by individual states to a national repeal campaign. ... GOP leaders hope at a minimum that they can energize conservative activists and turn the electorate against the Democrats in the crucial period after the law's enactment, when both parties would be fighting to define it in the public's mind before the November elections."
A new health economic analysis, published today online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor, dabigatran etexilate, is cost-effective compared to current treatment options, particularly in "real-world" clinical practice.
Politico: Some state insurance commissioners are not happy with a proposal that would give the federal government the authority to centralize premium rate reviews of health insurance.
› Verified 7 days ago
Mrs. Elena Agranovsky, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1857 86th St, Brooklyn, NY 11214 Phone: 718-232-1515 Fax: 718-232-1550 | |
Dr. Charles Y. Shao, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 450 Clarkson Ave, Box 25, Brooklyn, NY 11203 Phone: 718-270-6755 Fax: 718-270-3313 | |
Irina Meisher, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 2601 Ocean Pkwy, Brooklyn, NY 11235 Phone: 718-616-4408 Fax: 718-616-4105 | |
Mr. Archinto Peter Anzil, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 943 President St, Brooklyn, NY 11215 Phone: 718-622-4482 | |
Anne-marie Desrosiers, Pathology Medicare: Not Enrolled in Medicare Practice Location: 1545 Atlantic Ave, Brooklyn, NY 11213 Phone: 718-613-4000 | |
Dr. Hongbei Wang, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 450 Clarkson Avenue, Department Of Pathology, Box 25, Brooklyn, NY 11203 Phone: 718-270-4522 | |
Kathleen Rose Mccubbin, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 599 Winthrop St, Brooklyn, NY 11203 Phone: 718-604-4464 |